Correlation Between Cumberland Pharmaceuticals and Procaps Group
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Procaps Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Procaps Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Procaps Group SA, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Procaps Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Procaps Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Procaps Group.
Diversification Opportunities for Cumberland Pharmaceuticals and Procaps Group
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cumberland and Procaps is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Procaps Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procaps Group SA and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Procaps Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procaps Group SA has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Procaps Group go up and down completely randomly.
Pair Corralation between Cumberland Pharmaceuticals and Procaps Group
Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 1.0 times more return on investment than Procaps Group. However, Cumberland Pharmaceuticals is 1.0 times less risky than Procaps Group. It trades about 0.12 of its potential returns per unit of risk. Procaps Group SA is currently generating about -0.36 per unit of risk. If you would invest 235.00 in Cumberland Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of 24.34 from holding Cumberland Pharmaceuticals or generate 10.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cumberland Pharmaceuticals vs. Procaps Group SA
Performance |
| Timeline |
| Cumberland Pharmaceuticals |
| Procaps Group SA |
Cumberland Pharmaceuticals and Procaps Group Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cumberland Pharmaceuticals and Procaps Group
The main advantage of trading using opposite Cumberland Pharmaceuticals and Procaps Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Procaps Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procaps Group will offset losses from the drop in Procaps Group's long position.The idea behind Cumberland Pharmaceuticals and Procaps Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Procaps Group vs. Phibro Animal Health | Procaps Group vs. Delta 9 Cannabis | Procaps Group vs. City View Green | Procaps Group vs. Benchmark Botanics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |